1 Supplementary Information 1 for 2 3 Opposing effects of oxidative challenge and carotenoids on antioxidant 4 status and condition - dependent sexual signalling 5 6 Oldřich Tomášek , Barbora Gabrielová , Petr Kačer , Petr Maršík , Jana Svobodová , Kamila Syslová , 7 Michal Vinkler , Tomáš Albrecht 8 9 10 Supplementary inventory 11 Supplementary Data 12 Supplementary Table S1 . Group mean values and SD of measured variables at the beginning of the 13 experiment . 14 Supplementary Table S2 . Group mean values and SD of measured variables at the end of the 15 experiment . 16 Supplementary Table S3 . Standardised effect sizes of oxidative load ( ROS ) and carotenoid intake 17 ( CAR ) on beak hue and UV chroma and plasma lutein and zeaxanthin . 18 Supplementary Methods 19 Supplementary Table S4 . Validation parameters of the LC - MS methods for determination of HODEs 20 and 8 - iso - prostaglandin F 2α 21 2 Supplementary Table S1 . Group mean values and SD of measured variables at the beginning of the 22 experiment . 23 24 Treatment group ROS− CAR− ROS− CAR + ROS + CAR− ROS + CAR + Variable N Mean ( SD ) N Mean ( SD ) N Mean ( SD ) N Mean ( SD ) Beak red chroma 15 0 . 85 ( 0 . 04 ) 15 0 . 85 ( 0 . 03 ) 15 0 . 85 ( 0 . 03 ) 15 0 . 86 ( 0 . 03 ) Beak hue ( nm ) 15 590 . 33 ( 2 . 87 ) 15 590 . 20 ( 2 . 21 ) 15 588 . 93 ( 3 . 76 ) 15 589 . 07 ( 3 . 37 ) Beak UV chroma 15 0 . 018 ( 0 . 022 ) 15 0 . 015 ( 0 . 018 ) 15 0 . 011 ( 0 . 012 ) 15 0 . 007 ( 0 . 009 ) Total plasma carotenoids ( µg / mL ) 14 27 . 43 ( 3 . 18 ) 12 27 . 39 ( 8 . 36 ) 13 26 . 39 ( 5 . 18 ) 12 26 . 59 ( 7 . 93 ) Plasma lutein ( µg / mL ) 14 18 . 06 ( 3 . 17 ) 12 17 . 70 ( 4 . 52 ) 13 17 . 08 ( 3 . 01 ) 12 17 . 73 ( 5 . 40 ) Plasma zeaxanthin ( µg / mL ) 14 1 . 32 ( 0 . 85 ) 10 1 . 57 ( 1 . 07 ) 13 1 . 21 ( 0 . 56 ) 10 1 . 36 ( 1 . 43 ) 8 - isoprostanes in RBC ( pg / mL ) 15 33 . 49 ( 6 . 93 ) 14 37 . 06 ( 6 . 57 ) 15 34 . 90 ( 3 . 71 ) 14 36 . 20 ( 5 . 09 ) ZE / tHODE ratio 15 0 . 44 ( 0 . 02 ) 14 0 . 42 ( 0 . 02 ) 15 0 . 44 ( 0 . 02 ) 14 0 . 46 ( 0 . 01 ) OXY ( µmol HClO / mL ) 15 138 . 76 ( 30 . 16 ) 15 139 . 00 ( 26 . 52 ) 15 118 . 93 ( 27 . 28 ) 15 124 . 23 ( 27 . 02 ) Body mass ( g ) 15 16 . 39 ( 1 . 65 ) 15 17 . 20 ( 1 . 62 ) 15 16 . 02 ( 1 . 40 ) 15 17 . 33 ( 1 . 34 ) 3 Supplementary Table S2 . Group mean values and SD of measured variables at the end of the 25 experiment . 26 27 Treatment group ROS− CAR− ROS− CAR + ROS + CAR− ROS + CAR + Variable N Mean ( SD ) N Mean ( SD ) N Mean ( SD ) N Mean ( SD ) Beak red chroma 15 0 . 85 ( 0 . 02 ) 15 0 . 90 ( 0 . 01 ) 13 0 . 81 ( 0 . 03 ) 13 0 . 88 ( 0 . 03 ) Beak hue ( nm ) 15 588 . 33 ( 2 . 50 ) 15 595 . 73 ( 2 . 09 ) 13 583 . 69 ( 3 . 59 ) 13 592 . 38 ( 4 . 54 ) Beak UV chroma 15 0 . 010 ( 0 . 006 ) 15 0 . 003 ( 0 . 003 ) 13 0 . 020 ( 0 . 010 ) 13 0 . 005 ( 0 . 006 ) Total plasma carotenoids ( µg / mL ) 15 27 . 44 ( 4 . 91 ) 14 55 . 76 ( 13 . 40 ) 13 19 . 91 ( 6 . 99 ) 12 48 . 84 ( 17 . 11 ) Plasma lutein ( µg / mL ) 14 17 . 41 ( 3 . 46 ) 14 40 . 54 ( 9 . 63 ) 13 16 . 43 ( 5 . 17 ) 12 45 . 47 ( 15 . 02 ) Plasma zeaxanthin ( µg / mL ) 14 1 . 66 ( 0 . 89 ) 14 2 . 51 ( 1 . 59 ) 10 1 . 27 ( 0 . 92 ) 11 2 . 88 ( 1 . 94 ) 8 - isoprostanes in RBC ( pg / mL ) 15 27 . 41 ( 4 . 40 ) 15 30 . 54 ( 4 . 16 ) 13 30 . 46 ( 4 . 16 ) 10 31 . 65 ( 4 . 96 ) ZE / tHODE ratio 15 0 . 42 ( 0 . 02 ) 15 0 . 34 ( 0 . 03 ) 13 0 . 67 ( 0 . 04 ) 10 0 . 47 ( 0 . 02 ) OXY ( µmol HClO / mL ) 15 136 . 52 ( 29 . 97 ) 15 133 . 66 ( 28 . 21 ) 13 143 . 45 ( 42 . 42 ) 12 149 . 62 ( 25 . 32 ) Body mass ( g ) 15 16 . 71 ( 1 . 85 ) 15 17 . 93 ( 1 . 75 ) 13 16 . 85 ( 1 . 55 ) 13 17 . 15 ( 2 . 41 ) 4 Supplementary Table S3 . Standardised effect sizes of oxidative load ( ROS ) and carotenoid intake 28 ( CAR ) on beak hue and UV chroma and plasma lutein and zeaxanthin . Effect sizes are given as 29 standardised partial regression coefficients ( b * ) from linear models with oxidative load and carotenoid 30 intake as factors , initial values as covariates , and with continuous variables z - standardised . Low and 31 high factor levels were coded 0 and 1 , respectively and centred in order to enable the main effects to 32 be properly interpreted without the need to remove the interaction terms from the models . Beak UV 33 chroma and plasma lutein were normalised using logit and Box - Cox ( λ = 0 . 116 ) transformation , 34 respectively . 35 Response variables Standardised effect size Predictors b * 2 . 5 % CI 97 . 5 % CI Beak hue initial 0 . 25 0 . 10 0 . 40 ROS −0 . 61 −0 . 91 −0 . 31 CAR 1 . 42 1 . 12 1 . 70 ROS × CAR 0 . 13 −0 . 45 0 . 72 Beak UV chroma initial 0 . 16 −0 . 06 0 . 37 ROS 0 . 66 0 . 23 1 . 08 CAR −1 . 09 −1 . 51 −0 . 67 ROS × CAR −0 . 20 −1 . 03 0 . 64 Plasma lutein initial 0 . 28 0 . 15 0 . 41 ROS 0 . 05 −0 . 21 0 . 31 CAR 1 . 67 1 . 41 1 . 93 ROS × CAR 0 . 22 −0 . 30 0 . 74 Plasma zeaxanthin initial 0 . 53 0 . 31 0 . 76 ROS −0 . 16 −0 . 61 0 . 28 CAR 0 . 91 0 . 47 1 . 35 ROS × CAR 0 . 05 −0 . 83 0 . 94 36 5 Supplementary methods 37 HPLC analysis of carotenoids in plasma samples . Dried organic extract of the plasma ( see Material 38 and Methods ) was dissolved in a mobile phase ( methanol : acetonitrile 1 : 1 , v / v ) and injected ( 40 µl ) 39 into the HPLC . The HPLC system ( Q - grad quaternary pump , Watrex , Czech Republic ; Midas 40 autosampler , Spark , The Netherlands ) was equipped with a 4 . 6 x 250 mm 5 µm C30 Develosil RP - 41 Aqueous separation column with a C30 Develosil precolumn ( Nomura Chemical Co . , Japan ) . 42 Methanol ( A ) and acetonitrile ( B ) were used as mobile phases for gradient elution ( starting with 20 % 43 B , ramped to 45 % at 30 min , 100 % B from 33 to 43 min , followed by 10 min of equilibration with 44 20 % B ) . The flow was set to 1 mL / min and the column temperature set at 35 °C ( Mistral column 45 thermostat , Spark , The Netherlands ) . Absorption spectra ( range 300 – 600 nm ) were measured using a 46 DAD UV6000LP spectrometer ( Thermo Finnigan , USA ) . Carotenoids ( adonirubin , astaxanthin , 47 cryptoxanthin , lutein , zeaxanthin ) were identified by comparison of retention times and spectra with 48 commercially available standards ( Sigma - Aldrich , Czech Republic ; CaroteNature , Switzerland ) . 49 Quantitation of known carotenoids was performed at 450 and 470 nm using external standards . 50 51 HPLC analysis of oxidative damage and lipophilic antioxidant capacity in RBC . 52 Standards ( 13 - ( Z , E ) - HODE ) , 9 - ( Z , E ) - HODE , 8 - iso - prostaglandin F 2  ( 8 - isoprostane ) , 53 9 - HODE - d 4 and 13 - HODE - d 4 and 8 - iso - prostaglandin F 2  - d 4 ) were obtained from Cayman Chemical 54 Company ( MI , USA ) . 9 - ( E , E ) - HODE and 13 - ( E , E ) - HODE were obtained from Larodan Fine 55 Chemicals AB ( Malmo , Sweden ) . 56 The pre - treatment step was performed according to the following procedure : internal standards 57 9 - HODE - d 4 , 13 - HODE - d 4 and 8 - iso - prostaglandin F 2  - d 4 ( each internal standard was 10 ng / 50 µL of 58 RBC ) , butylated hydroxytoluene ( 100 µM – antioxidant ) and an extraction solution of methanol and 59 acetonitrile ( 100 µL of methanol and 100 µL of acetonitrile / 50 µL of RBC ) were added to the RBC . 60 The mixture and RBC were sonicated for 10 min at 4 °C . The sample was then centrifuged at 61 9 , 000 × g at a temperature of 4 °C and the supernatant subsequently separated . The supernatant was 62 6 dried by stripping with nitrogen then dissolved in methanol and water ( 25 µL , methanol : water – 70 : 30 63 v / v ) and immediately analysed by HPLC - ESI - MS / MS . 64 The LC - ESI - MS / MS system consisted of an Accela 1250 LC chromatogram ( Thermo Scientific , 65 USA ) , an Open Accela autosampler ( Thermo Scientific , USA ) and a TSQ Vantage mass spectrometer 66 ( Thermo Scientific , USA ) . The analytes were separated on a 100 × 2 . 1 mm 1 . 7 μm C18 Kinetex 67 column ( Phenomenex , USA ) with a mobile phase ( solvent A : 5 mM ammonium acetate , Solvent B : 68 acetonitrile , solvent C : methanol ) in a gradient elution with a flow rate of 200 µL / min . The HPLC 69 elution program was as follows : 75 % A , 20 % B , 5 % C ( 3 min ) → 50 % A , 45 % B , 5 % C ( linear 70 increase over 40 min , held for 5 min ) → 75 % A , 20 % B , 5 % C ( linear decrease over 1 min , held for 71 5 min ) . The column temperature was maintained at 30 °C and the sample temperature at 4 °C . 72 Injection volume was 10 µL . The analytes were eluted with the following retention times : 73 9 - ( ZE ) - HODE = 36 . 6 min , 9 - ( EE ) - HODE = 39 . 2 min , 13 - ( ZE ) - HODE = 35 . 4 min , 74 13 - ( EE ) - HODE = 37 . 2 min , and 8 - iso - prostaglandin F 2  = 9 . 4 min . A mass spectrometer equipped 75 with electrospray ionisation ( ESI ) was used for detecting HODEs , 8 - iso - prostaglandin F 2  and their 76 deuterium labelled internal standards ( 9 - HODE - d 4 , 13 - HODE - d 4 , 8 - iso - prostaglandin F 2  - d 4 ) in 77 negative ionisation mode ( ESI - ) . The selective reaction monitoring mode was used . The scan 78 monitoring reactions ( precursor ion → fragment ion ) used for the analyses and their collision induced 79 dissociated ( CID ) energy were as follows : m / z = 295 . 4 Da ( corresponding with [ M - H ] - ions ) → 80 m / z = 171 . 5 Da ( corresponding with fragmentation ion ) ( CID = 22eV ) for 9 - ( ZE ) - HODE and 81 9 - ( EE ) - HODE ; m / z = 299 . 4 Da → m / z = 175 . 5 Da ( CID = 22eV ) for 9 - HODE - d 4 ; m / z = 295 . 4 Da → 82 m / z = 194 . 6 Da ( CID = 21eV ) for 13 - ( ZE ) - HODE ; and 13 - ( EE ) - HODE , m / z = 299 . 4 Da → 83 m / z = 198 . 6 Da ( CID = 21eV ) for 13 - HODE - d 4 ; m / z = 299 . 4 Da → m / z = 198 . 6 Da ( CID = 21eV ) ; 84 m / z = 353 . 5 Da → m / z = 193 . 1 Da ( CID = 22eV ) for 8 - iso - prostaglandin F 2   and m / z = 357 . 5 Da → 85 m / z = 197 . 1 Da ( CID = 22eV ) for 8 - iso - prostaglandin F 2  - d 4 . The optimised conditions on the mass 86 spectrometer were as follows : spray voltage = 2500 V , temperature of ion transfer tube = 300 °C , 87 temperature of H - ESI vaporiser = 300 °C , pressure of sheath gas ( nitrogen ) = 35 psi , and flow of 88 7 auxiliary gas ( nitrogen ) set at 10 arbitrary units . The data were acquired and processed using Xcalibur 89 v . 2 . 1 . 0 software ( Thermo Scientific , USA ) . 90 The validation parameters ( accuracy , precision , recovery and limit of detection and 91 quantification ) were assessed by analysing five different concentration levels ( LOQ , 5 , 10 , 50 and 92 100 pg /  l ) of the particular substances ( 9 - ( ZE ) - HODE , 9 - ( EE ) - HODE , 13 - ( ZE ) - HODE , 93 13 - ( EE ) - HODE , and 8 - iso - prostaglandin F 2  . The values of the validation parameters for each 94 particular substrate were summarised in Supplementary table S2 . 95 96 Table S4 . Validation parameters of the LC - MS methods for determination of HODEs and 97 8 - iso - prostaglandin F 2a 98 Analyte Precision Accuracy Recovery LOD LOQ RSD ( % ) RE ( % ) ( % ) ( pg /  l ) ( pg /  l ) 9 - ( ZE ) - HODE 16 . 7 −15 . 9 84 . 1 0 . 04 0 . 05 9 - ( EE ) - HODE 16 . 5 −16 . 2 83 . 8 0 . 05 0 . 06 13 - ( ZE ) - HODE 18 . 3 −14 . 8 85 . 2 0 . 06 0 . 07 13 - ( EE ) - HODE 18 . 1 −15 . 0 85 . 0 0 . 05 0 . 06 8 - iso - PGF 2  14 . 6 −12 . 8 87 . 2 0 . 08 0 . 09 99